Eli Lilly
LLY
$749.14
Share price
-0.22%
Change (1 day)
101.19%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Eli Lilly (LLY) - Cash on Hand
Cash on Hand as of December 2023 : $2.92 B
According to Eli Lilly's latest financial reports the company has $2.92 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Eli Lilly - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $2.92 B | 32.37% |
| 2022-12-31 | $2.21 B | -43.41% |
| 2021-12-31 | $3.90 B | 6.17% |
| 2020-12-31 | $3.68 B | 50.97% |
| 2019-12-31 | $2.43 B | -67.09% |
| 2018-12-31 | $7.40 B | -7.78% |
| 2017-12-31 | $8.03 B | 33.05% |
| 2016-12-31 | $6.03 B | 35.64% |
| 2015-12-31 | $4.45 B | -7.77% |
| 2014-12-31 | $4.82 B | -10.57% |
| 2013-12-31 | $5.39 B | -5.05% |
| 2012-12-31 | $5.68 B | -17.58% |
| 2011-12-31 | $6.89 B | 2.53% |
| 2010-12-31 | $6.72 B | 49.57% |
| 2009-12-31 | $4.49 B | -24.11% |
| 2008-12-31 | $5.92 B | 22.66% |
| 2007-12-31 | $4.83 B | 24.16% |
| 2006-12-31 | $3.89 B | -22.76% |
| 2005-12-31 | $5.03 B | -32.51% |
| 2004-12-31 | $7.46 B | 101.02% |
| 2003-12-31 | $3.71 B | 1.6% |
| 2002-12-31 | $3.65 B | -2.05% |
| 2001-12-31 | $3.73 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 683.11% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 376.89% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 333.45% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 337.75% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 273.81% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 239.11% | 🇫🇷 France |
 Merck MRK | $7.09 B | 142.27% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 319.44% | 🇺🇸 USA |
 AstraZeneca AZN | $5.86 B | 100.16% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $6.35 B | 117.06% | 🇬🇧 UK |